Decision Diagnostics Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DECN research report →
Price Chart
About the company
Decision Diagnostics Corp. (DECN), founded in 2000 and based in Westlake Village, California, specializes in developing electronic medical record (EMR) technologies primarily optimized for smartphones. The company provides a wide array of offerings, including both regulated and unregulated diagnostic solutions, as well as home-use testing products for individuals managing chronic illnesses.
- CEO
- Keith Berman
- IPO
- 2002
- Employees
- 6
- HQ
- Westlake Village, CA, US
Get TickerSpark's AI analysis on DECN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $35.79K
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.02
- P/B
- 0.06
- EV/EBITDA
- -1.01
- Div Yield
- 0.00%
- Gross Margin
- 25.18%
- Op Margin
- -106.68%
- Net Margin
- -1499.05%
- ROE
- -10388.57%
- ROIC
- -57.78%
Latest fiscal year · YoY change
- Revenue
- $1.98M-16.8%
- Gross Profit
- $498.45K-41.4%
- Op Income
- $-2,111,432
- Net Income
- $-29,668,622-847.2%
- EPS
- $-0.11-428.8%
- OCF Growth
- -26.0%
- FCF Growth
- -14.1%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.05
- RSI (14)
- 36
- Avg Volume
- 1.29M
No earnings-call transcripts are available for DECN yet.
- Free Float
- 106.2%
- Shares Outstanding
- 357.87M
- Float Shares
- 379.97M
Our DECN coverage
Recent articles, reports, and earnings notes.
No research on DECN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DECN report →Financial Review: 10x Genomics (NASDAQ:TXG) & Decision Diagnostics (OTCMKTS:DECN)
defenseworld.net · Feb 20
Decision Diagnostics (OTCMKTS:DECN) vs. Privia Health Group (NASDAQ:PRVA) Critical Contrast
defenseworld.net · Dec 20
Head-To-Head Analysis: Decision Diagnostics (OTCMKTS:DECN) vs. Strata Skin Sciences (NASDAQ:SSKN)
defenseworld.net · Nov 19
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
newsfilecorp.com · Mar 14
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
prnewswire.com · Mar 12
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
prnewswire.com · Mar 3
DECN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Decision Diagnostics Corp. Investors of Class Action and Encourages Shareholders to Contact the Firm
businesswire.com · Feb 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.